Novanta (NOVT)
NASDAQ:NOVT
Want to see NOVT full AI Analyst Report?
NOVT Stock Chart & Stats
$128.85
$0.12(0.08%)
At close: 4:00 PM EST
$128.85
$0.12(0.08%)
Day’s Range― - ―
52-Week Range$98.27 - $171.85
Previous CloseN/A
Volume75.58K
Average Volume (3M)532.18K
Market Cap
$5.78B
Enterprise Value$5.58B
Total Cash (Recent Filing)$388.80M
Total Debt (Recent Filing)$291.33M
Price to Earnings (P/E)120.8
Beta1.62
Next Earnings
Aug 11, 2026EPS Estimate
0.83Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.40
Shares Outstanding35,611,860
10 Day Avg. Volume567,949
30 Day Avg. Volume532,179
Financial Highlights & Ratios
PEG Ratio-4.64
Price to Book (P/B)3.31
Price to Sales (P/S)4.44
P/FCF Ratio89.90
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue5.55
Enterprise Value/Gross Profit13.38
Enterprise Value/Ebitda37.23
Forecast
1Y Price Target
$180.00Price Target Upside39.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)3.56
Revenue Forecast (FY)$1.05B
Bulls Say, Bears Say
Bulls Say
Improved Balance SheetMaterial deleveraging and a net cash position strengthen Novanta's financial flexibility for the next several quarters. A stronger capital structure reduces refinancing and liquidity risk, supports disciplined M&A or capex, and provides buffer against cyclical end-market swings.
New Product MomentumRapid new-product adoption and rising design wins imply deeper OEM integration and higher content per machine over time. A steady pipeline increases recurring revenue potential, strengthens pricing power, and helps sustain margins as products embed into customer platforms.
Strategic Medical AcquisitionAcquiring Riverpoint materially shifts Novanta toward higher recurring medical consumables revenue, adds IP-protected products and U.S./Costa Rica manufacturing, and expands addressable market. This structural move should deepen OEM relationships and stabilize long-term revenue streams.
Bears Say
Acquisition Leverage & Execution RiskThe Riverpoint acquisition meaningfully increases leverage near term, constraining financial flexibility and elevating refinancing and covenant risk. Integration/regulatory execution demands can divert management attention, heightening the chance synergies or cash flow benefits are delayed or reduced.
Margin Pressure From TariffsSustained supply‑chain cost inflation and abrupt tariff shifts create repricing lags that compress gross margins. If cost dynamics persist or competitive friction limits price recovery, margin restoration may be slower, reducing cash flow and margin sustainability over multiple quarters.
Volatile Cash Conversion & Lower ROEInconsistent operating cash conversion and declining ROE reduce predictability of internally generated funding for capex, acquisitions, or deleveraging. That variability raises execution risk for multi-quarter initiatives and complicates sustaining returns as the company grows recurring revenue.
Novanta News
NOVT FAQ
What was Novanta’s price range in the past 12 months?
Novanta lowest stock price was $98.27 and its highest was $171.85 in the past 12 months.
What is Novanta’s market cap?
Novanta’s market cap is $5.78B.
When is Novanta’s upcoming earnings report date?
Novanta’s upcoming earnings report date is Aug 11, 2026 which is in 59 days.
How were Novanta’s earnings last quarter?
Novanta released its earnings results on May 11, 2026. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.777 by $0.033.
Is Novanta overvalued?
According to Wall Street analysts Novanta’s price is currently Undervalued.
Does Novanta pay dividends?
Novanta does not currently pay dividends.
What is Novanta’s EPS estimate?
Novanta’s EPS estimate is 0.83.
How many shares outstanding does Novanta have?
Novanta has 35,611,860 shares outstanding.
What happened to Novanta’s price movement after its last earnings report?
Novanta reported an EPS of $0.81 in its last earnings report, beating expectations of $0.777. Following the earnings report the stock price went up 13.723%.
Which hedge fund is a major shareholder of Novanta?
Currently, no hedge funds are holding shares in NOVT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Novanta Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$180.00 (39.70% Upside)
$180.00 (39.70% Upside)
Blogger Sentiment
Bullish
NOVT Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 13.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.7%
Last 30 Days ▲ 21.4%
Last 30 Days ▲ 21.4%
News Sentiment
Bullish
Bullish news 71%
Bearish news 29%
Bearish news 29%
Technicals
SMA
Positive
20 days / 200 days
Momentum
27.12%
12-Months-Change
Fundamentals
Return on Equity
5.08%
Trailing 12-Months
Asset Growth
29.85%
Trailing 12-Months
Company Description
Novanta
Operating globally, Novanta Inc. and its affiliated companies specialize in the development, production, and distribution of advanced photonics, vision, and precision motion components and sub-assemblies. These highly engineered solutions are supplied to Original Equipment Manufacturers (OEMs) across the medical and industrial sectors. Within its Photonics division, Novanta provides a suite of laser-driven technologies. These encompass systems for laser scanning, beam manipulation, and various laser types such as CO2, solid-state, ultrafast, and optical light engines. Their applications span critical areas like industrial manufacturing, precision measurement (metrology), advanced imaging in healthcare and biological research, DNA sequencing, and specialized medical laser treatments. The Vision segment delivers an array of medical-grade innovations. This portfolio comprises instruments like medical insufflators, pumps, and their associated consumables, alongside comprehensive visualization tools. It also features wireless communication systems, video recording devices, and integration platforms designed for operating theaters. Further offerings include optical data acquisition, machine vision systems, radio frequency identification (RFID) solutions, thermal recording devices, spectrometry equipment, and integrated touchscreen displays. Furthermore, the Precision Motion division specializes in supplying components such as optical and inductive encoders, high-precision motors, servo drives, and complete motion control systems. This segment also delivers integrated stepper motors, sophisticated robotic end-effectors, air bearings, and air bearing spindles. Novanta distributes its extensive product lines through various channels, including its dedicated direct sales team, value-added resellers, distribution partners, and system integrators. These offerings are available under well-known brand names such as Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind. Founded in 1968, the company operated as GSI Group, Inc. until its rebranding to Novanta Inc. in May 2016. Its corporate headquarters are located in Bedford, Massachusetts.
NOVT Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum: robust bookings (+37%), improving organic growth trajectory, expanding profitability (adjusted EBITDA +14%, margin +70 bps), accelerating new product revenue (+~50%) and excellent cash generation (>200% cash conversion). These positives were tempered by near-term gross margin pressure from sudden tariff and freight cost increases, a modest $0.03 EPS headwind, and timing risk as repricing and manufacturing consolidation benefits are expected to materialize in the back half of the year. Management reaffirmed and tightened full-year guidance and outlined clear actions (surcharges, price increases, site consolidations) to restore margins, leaving the overall tone constructive.View all NOVT earnings summariesNOVT Stock 12 Month Forecast
Average Price Target
$180.00
▲(39.70% Upside)
Technical Analysis
Ownership Overview
0.79% Insiders
43.99% Mutual Funds
25.77% Other Institutional Investors
0.19% Public Companies and
Individual Investors